Joint imaging platform for federated clinical data analytics
PURPOSE Image analysis is one of the most promising applications of artificial intelligence
(AI) in health care, potentially improving prediction, diagnosis, and treatment of diseases …
(AI) in health care, potentially improving prediction, diagnosis, and treatment of diseases …
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic
abnormality in Waldenström macroglobulinaemia (WM), occurring in approximately 50% of …
abnormality in Waldenström macroglobulinaemia (WM), occurring in approximately 50% of …
Development and validation of a simplified score to predict early relapse in newly diagnosed multiple myeloma in a pooled dataset of 2,190 patients
GM Zaccaria, L Bertamini, MT Petrucci, M Offidani… - Clinical Cancer …, 2021 - AACR
Purpose: Despite the improvement of therapeutic regimens, several patients with multiple
myeloma (MM) still experience early relapse (ER). This subset of patients currently …
myeloma (MM) still experience early relapse (ER). This subset of patients currently …
A clinical prognostic model based on machine learning from the Fondazione Italiana Linfomi (FIL) MCL0208 phase III trial
GM Zaccaria, S Ferrero, E Hoster, R Passera… - Cancers, 2021 - mdpi.com
Simple Summary The interest in using Machine-Learning (ML) techniques in clinical
research is growing. We applied ML to build up a novel prognostic model from patients …
research is growing. We applied ML to build up a novel prognostic model from patients …
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology
GM Zaccaria, V Colella, S Colucci, F Clemente… - Scientific Reports, 2021 - nature.com
The unstructured nature of Real-World (RW) data from onco-hematological patients and the
scarce accessibility to integrated systems restrain the use of RW information for research …
scarce accessibility to integrated systems restrain the use of RW information for research …
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
S Ferrero, D Grimaldi, E Arrigoni, M Pironti… - Blood …, 2023 - ashpublications.org
Abstract In the Fondazione Italiana Linfomi MCL0208 phase 3 trial, lenalidomide
maintenance (LEN) after autologous stem cell transplantation (ASCT) in mantle cell …
maintenance (LEN) after autologous stem cell transplantation (ASCT) in mantle cell …
[HTML][HTML] Minimal residual disease (MRD) in mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare, aggressive non-Hodgkin lymphoma (NHL)
characterized by considerable biological and clinical heterogeneity. A number of baseline …
characterized by considerable biological and clinical heterogeneity. A number of baseline …
[PDF][PDF] Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
NCF ABCB - 2023 - arpi.unipi.it
Mantle cell lymphoma (MCL) is an aggressive, mature B-cell non-Hodgkin lymphoma
historically known for its poor long-term outcome. 1 In recent years, the introduction of novel …
historically known for its poor long-term outcome. 1 In recent years, the introduction of novel …
[PDF][PDF] LENALIDOMIDE VS OSSERVAZIONE NEL LINFOMA MANTELLARE: RISULTATI CLINICI E MOLECOLARI A LUNGO TERMINE DI UNO STUDIO DI FASE III
A MAZZOCATO - 2023 - unitesi.uniupo.it
Lo studio di fase III FIL MCL0208 ha confrontato l'utilizzo di LEN per due anni con
l'osservazione (OBS) dopo il trapianto autologo di cellule staminali (ASCT) in giovani (< 65 …
l'osservazione (OBS) dopo il trapianto autologo di cellule staminali (ASCT) in giovani (< 65 …